Top 7 CBD Stocks Ripe For Investment In 2021

By Nancy R. Fernandez

The mainstream has seen a significant surge in CBD products since the Farm Bill’s passing in December 2018. Now, these products are available for purchase in retailers such as Walgreens, CVS, and Kroger. 

According to predictions made by BDS Analytics, a cannabis market research firm based in Boulder, CBD should surpass $20 billion by 2024. So how do you take advantage of this boost by investing in CBD stocks? A Beginners Guide to Cannabis or CBD is a must-read before proceeding.

Here are seven top CBD stocks to buy for the remainder of 2021.

Tilray (NASDAQ: TLRY)

The IPO of Tilray hit $300 on an intra-day, which is very remarkable for a CBD stock and set the company up for an impressive start. In the case of TLRY, the rest of the road has been so smooth since it flew so high. 

Last year, the company had some of the worst losses ever recorded in the industry. It opened 2019 at $70. However, the stocks of Tilray followed a downward trend since March. By the time the year was coming to an end, TLRY stock prices had reduced 75% in value. 

Hence, it’s reasonable if investors aren’t lining up to put money behind this company. However, the rising interest in medicinal marijuana at the national and international levels could provide the company and other industry-leading producers of CBD oil such as   Medterra a perfect remedy. 

Holdings (OTCMKTS: CURLF)

In …

Full story available on Benzinga.com

More Top 7 CBD Stocks Ripe For Investment In 2021